Clinical Trials
3 trialsNCT03913117 2026-05-15
PVX-6
University of Alabama at Birmingham
Phase 1 Recruiting
NCT01149343 2020-11-20
Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer
GlaxoSmithKline
Phase 1 Completed
NCT02689726 2016-12-02
Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
Genticel
Phase 1 Terminated